WellCare's stock jumps 23% after Centene announces merger valued at $17.3 billion

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 6 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 6%
  • Publisher: 97%

United States News News

United States United States Latest News,United States United States Headlines

WellCare's stock jumps 23% after Centene announces merger worth $17.3 billion

Health-care company Centene Corp. CNC, -3.86% on Wednesday announced plans to purchase managed-care provider WellCare Health Plans Inc. WCG, -3.93% St. Louis-based Centene said it would buy WellCare, based in Tampa, Florida, for $305.39 per share, with the deal valued at $17.3 billion. Bloomberg News on Tuesday reported that the health-care companies were in merger talks.

Have breaking news sent to your inbox. Subscribe to MarketWatch's free Bulletin emails. Sign up here.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in US
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

thanks for updates ODPP

United States United States Latest News, United States United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Levi Strauss, Valued At $6.6 Billion, Is Making A Comeback As A Public CompanyThe 165-year-old company that invented blue jeans still makes most of its money from men’s pants, but that's changing. Now it's time for Levi Ackerman to make a comeback as humanity's strongest My favorite jeans Levi's jeans for life
Source: Forbes - 🏆 394. / 53 Read more »

Boeing has lost $40 billion-plus in market value since Ethiopia crashBoeing is having a horrible month. looking for logos of your company / business / website /brand or other events ....? go and order now And the 401k gamble continues. Huh! safetyMatters
Source: CNN - 🏆 4. / 95 Read more »

Biogen scraps Alzheimer drug trials, wiping $17 billion off its market valueReuters - Biogen and partner Eisai Co Ltd are ending two late-stage trials for t... This sucks. Did they forget? 😂
Source: Reuters - 🏆 2. / 97 Read more »